Lingxiang Jin

653 total citations
18 papers, 518 citations indexed

About

Lingxiang Jin is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Lingxiang Jin has authored 18 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Lingxiang Jin's work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Lingxiang Jin is often cited by papers focused on MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Lingxiang Jin collaborates with scholars based in China, Spain and France. Lingxiang Jin's co-authors include Chenwei Pan, Zhenzhen Pan, Guangyao Zhou, Wei Lin, Yi Zheng, Peipei Fang, Changlong Xu, Weilai Chen, Jie Li and Yongping Chen and has published in prestigious journals such as PLoS ONE, European Journal of Pharmacology and Oncotarget.

In The Last Decade

Lingxiang Jin

18 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingxiang Jin China	11	292	177	110	63	61	18	518
Xianan Sang China	13	294 1.0×	159 0.9×	95 0.9×	63 1.0×	43 0.7×	34	551
Kwang-Youn Kim South Korea	13	231 0.8×	54 0.3×	81 0.7×	77 1.2×	37 0.6×	42	475
Shidong Xu China	7	328 1.1×	196 1.1×	85 0.8×	26 0.4×	48 0.8×	9	546
Sam Seok Cho South Korea	17	373 1.3×	147 0.8×	257 2.3×	68 1.1×	41 0.7×	27	794
Dujuan Xu China	16	354 1.2×	93 0.5×	63 0.6×	128 2.0×	56 0.9×	33	661
Biyun Lin China	11	232 0.8×	66 0.4×	82 0.7×	42 0.7×	53 0.9×	21	426
Yigang Feng Hong Kong	7	173 0.6×	93 0.5×	85 0.8×	72 1.1×	42 0.7×	9	362
Shu Dai China	13	193 0.7×	61 0.3×	86 0.8×	66 1.0×	47 0.8×	24	452
Chenkai Huang China	14	255 0.9×	90 0.5×	225 2.0×	76 1.2×	41 0.7×	26	517
Xinying Zhu China	12	403 1.4×	199 1.1×	60 0.5×	40 0.6×	107 1.8×	16	664

Countries citing papers authored by Lingxiang Jin

Since Specialization

Citations

This map shows the geographic impact of Lingxiang Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxiang Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxiang Jin more than expected).

Fields of papers citing papers by Lingxiang Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingxiang Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxiang Jin. The network helps show where Lingxiang Jin may publish in the future.

Co-authorship network of co-authors of Lingxiang Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Lingxiang Jin. A scholar is included among the top collaborators of Lingxiang Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingxiang Jin. Lingxiang Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Huang, Shanshan, Zheng Zhu, Lingxiang Jin, et al.. (2023). Prognostic factors and survival prediction in hepatocellular carcinoma: development and validation of a novel nomogram based on the SEER database. Journal of Gastrointestinal Oncology. 14(4). 1817–1829. 4 indexed citations

Li, Shaoxun, Weilai Chen, Peipei Fang, et al.. (2020). Mangiferin alleviates endoplasmic reticulum stress in acute liver injury by regulating the miR-20a/miR-101a-Nrf2 axis. The Journal of Biochemistry. 168(4). 365–374. 12 indexed citations

Jin, Lingxiang, et al.. (2019). Increased Levels of miR-155 are Related to Higher T-Cell Activation in the Peripheral Blood of Patients with Chronic Hepatitis B. Genetic Testing and Molecular Biomarkers. 23(2). 118–123. 10 indexed citations

Fang, Peipei, Weilai Chen, Shaoxun Li, et al.. (2019). LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3. Innate Immunity. 25(2). 99–109. 81 indexed citations

Zhang, Lingling, Linong Yao, Jie Li, et al.. (2018). Human babesiosis in Southeast China: A case report. International Journal of Infectious Diseases. 68. 36–38. 4 indexed citations

Fang, Peipei, Lingxiang Jin, Guangyao Zhou, et al.. (2018). IRE1α‑XBP1 signaling pathway regulates IL‑6 expression and promotes progression of hepatocellular carcinoma. Oncology Letters. 16(4). 4729–4736. 36 indexed citations

Fang, Peipei, Jie Li, Chen‐Wei Pan, et al.. (2018). Lentinan relieves hepatitis B surface antigen induced functional impairment of monocytes/macrophages. Tropical Journal of Pharmaceutical Research. 17(4). 583–583. 1 indexed citations

Zheng, Yi, Jie Li, Chenwei Pan, et al.. (2017). HERC4 Is Overexpressed in Hepatocellular Carcinoma and Contributes to the Proliferation and Migration of Hepatocellular Carcinoma Cells. DNA and Cell Biology. 36(6). 490–500. 7 indexed citations

Yi, Yongxiang, Peipei Fang, Chenwei Pan, et al.. (2017). Shikonin protects against D-Galactosamine and lipopolysaccharide-induced acute hepatic injury by inhibiting TLR4 signaling pathway. Oncotarget. 8(53). 91542–91550. 9 indexed citations

10.

Xu, Changlong, Liang Shi, Weilai Chen, et al.. (2017). MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4. Oncotarget. 8(26). 41921–41931. 21 indexed citations

11.

Zhou, Guangyao, Yongxiang Yi, Lingxiang Jin, et al.. (2016). The protective effect of juglanin on fructose-induced hepatitis by inhibiting inflammation and apoptosis through TLR4 and JAK2/STAT3 signaling pathways in fructose-fed rats. Biomedicine & Pharmacotherapy. 81. 318–328. 54 indexed citations

12.

Zhou, Guangyao, et al.. (2016). MiR-10a improves hepatic fibrosis by regulating the TGFβl/Smads signal transduction pathway. Experimental and Therapeutic Medicine. 12(3). 1719–1722. 9 indexed citations

13.

Pan, Chenwei, Xiaodong Wang, Keqing Shi, et al.. (2016). MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism. PLoS ONE. 11(5). e0152090–e0152090. 64 indexed citations

14.

Zhou, Guangyao, Chenwei Pan, Lingxiang Jin, Jianjian Zheng, & Yongxiang Yi. (2016). Neoalbaconol inhibits cell growth of human cholangiocarcinoma cells by up-regulating PTEN.. PubMed. 8(2). 496–505. 2 indexed citations

15.

Xu, Changlong, Bihuan Cheng, Lingxiang Jin, et al.. (2015). Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapy. Tumor Biology. 37(1). 331–339. 26 indexed citations

16.

Pan, Chenwei, Zhenzhen Pan, Guangyao Zhou, et al.. (2015). Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. European Journal of Pharmacology. 770. 85–91. 95 indexed citations

17.

Pan, Chenwei, Guangyao Zhou, Lingxiang Jin, et al.. (2015). Protective effect of forsythiaside A on lipopolysaccharide/d-galactosamine-induced liver injury. International Immunopharmacology. 26(1). 80–85. 64 indexed citations

18.

Pan, Chenwei, Xiaodong Wang, Weilai Chen, et al.. (2014). Reevaluation of glypican-3 as a prognostic marker in HCC using X-tile software. Medical Oncology. 32(1). 359–359. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact